APAC Healthcare Weekly (May 31) – Innovent Biologics, Junshi Bio, Henlius Bio, Olympus, GC Bio
Innovent stuck $10.5B outlicensing deal with Pfizer. Olympus will acquire BioProtect. Eli Lilly is acquiring GC Bio’s US affiliate. Dong-A’s...
89 Views
𝛼SK or SearchENTITY
CF PharmTech (2652 HK)
CF PharmTech (2652 HK)
1
Analysis
Health Care • China
CF PharmTech is a specialty pharmaceutical company focused on the research, development, manufacturing, and commercialization of inhalation technologies and respiratory drugs. The company specializes in treatments for asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis, with key products including budesonide suspension for inhalation and azelastine hydrochloride and fluticasone propionate nasal spray. Headquartered in Suzhou, China, the company was founded in 2007.
morex